HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?

AuthorsGiuseppina Abignano, Lesley-Anne Bissell, Paul Emery, Francesco Del Galdo, Maya H Buch
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 55 Issue 12 Pg. 2273-2275 (12 2016) ISSN: 1462-0332 [Electronic] England
PMID27744357 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Methylprednisolone
Topics
  • Cyclophosphamide (administration & dosage)
  • Disease Management
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (administration & dosage)
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Lung Diseases, Interstitial (drug therapy, etiology)
  • Male
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Scleroderma, Systemic (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: